Safety and pharmacokinetics of amprenavir (141W94), a human immunodeficiency virus (HIV) type 1 protease inhibitor, following oral administration of single doses to HIV-infected adults.

Source:http://linkedlifedata.com/resource/pubmed/id/10390223

Download in:

View as

General Info

PMID
10390223